亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Patient value co-creation behavior scale based on the DART model

投掷 比例(比率) 价值(数学) 计算机科学 地理 地图学 机器学习 程序设计语言
出处
期刊:The American Journal of Managed Care [Managed Care and Healthcare Communications, LLC]
卷期号:26 (9): e282-e288 被引量:6
标识
DOI:10.37765/ajmc.2020.88493
摘要

Value co-creation focuses on customer participation and co-creates value with suppliers. Patients' support and cooperation can improve the quality of medical care. Value creation is closely related to participants' behavior. The DART (Dialogue, Access, Risk assessment, Transparency) model is widely used in commercial research because it defines and classifies value co-creation behavior clearly and systematically. However, there is little research using the DART model in the field of health care. This study aimed to develop and evaluate the psychometric properties of a scale measuring patient value co-creation behavior based on the DART model.The Delphi technique was used to determine the scale content with a panel of 17 experts. A cross-sectional survey was administered to 356 outpatients and inpatients of a hospital in Guangzhou, China.Internal consistency reliability and composite reliability (CR) were used to estimate the scale's reliability. Validity was assessed using convergent and discriminant validity.Three rounds of expert consultation were completed before a final consensus was reached regarding scale content. The patient value co-creation behavior scale was composed of 23 items and 4 dimensions. The overall Cronbach's α was 0.934, and the CRs of the 4 DART dimensions were 0.843, 0.872, 0.911, and 0.884, respectively, showing satisfactory reliability. The average variance extracted ranged from 0.473 to 0.659, and the χ2 difference between constrained and free models was significant, indicating convergent and discriminant validity.The scale exhibited acceptable reliability and validity and could serve as an evaluation tool for patient value co-creation behavior.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
RTena.完成签到,获得积分10
5秒前
7秒前
标致如霜完成签到,获得积分10
10秒前
10秒前
zxx完成签到 ,获得积分10
13秒前
标致如霜发布了新的文献求助10
14秒前
20秒前
SciGPT应助大力的无声采纳,获得10
24秒前
科目三应助大力的无声采纳,获得10
24秒前
24秒前
JamesPei应助大力的无声采纳,获得10
24秒前
脑洞疼应助大力的无声采纳,获得10
24秒前
25秒前
wh雨完成签到,获得积分10
25秒前
阿豪要发文章完成签到 ,获得积分10
33秒前
34秒前
38秒前
38秒前
38秒前
39秒前
科研通AI5应助崔崔采纳,获得10
41秒前
李健应助崔崔采纳,获得10
41秒前
合适夜绿发布了新的文献求助10
43秒前
wh雨发布了新的文献求助10
45秒前
49秒前
NexusExplorer应助atad2采纳,获得10
50秒前
科研通AI5应助wh雨采纳,获得10
53秒前
剑八发布了新的文献求助10
55秒前
阿巴完成签到 ,获得积分10
1分钟前
田田田完成签到,获得积分10
1分钟前
CipherSage应助剑八采纳,获得10
1分钟前
科研通AI5应助Blast采纳,获得30
1分钟前
酷波er应助科研通管家采纳,获得10
1分钟前
jyy应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
科研通AI5应助科研通管家采纳,获得10
1分钟前
1分钟前
yanxueyi完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
1.3μm GaAs基InAs量子点材料生长及器件应用 1000
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3526498
求助须知:如何正确求助?哪些是违规求助? 3106931
关于积分的说明 9281903
捐赠科研通 2804438
什么是DOI,文献DOI怎么找? 1539468
邀请新用户注册赠送积分活动 716571
科研通“疑难数据库(出版商)”最低求助积分说明 709554